Alan A. Musso - 31 Oct 2023 Form 4 Insider Report for AILERON THERAPEUTICS INC (ALRN)

Role
Director
Signature
/s/ Manuel C. Alves-Aivado, M.D., Ph.D., as attorney-in-fact for Alan Musso
Issuer symbol
ALRN
Transactions as of
31 Oct 2023
Net transactions value
$0
Form type
4
Filing time
02 Nov 2023, 20:53:07 UTC
Previous filing
09 Aug 2023
Next filing
19 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +5,450 $0.000000 5,450 31 Oct 2023 Common Stock 5,450 $1.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on October 31, 2023. The shares underlying the option are scheduled to vest over 48 equal monthly installments from October 31, 2023, subject to continued service.